Russell Frank Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$15.4M Sell
193,507
-62,759
-24% -$5.68M 0.03% 718
2015
Q4
$32.4M Sell
256,266
-111,770
-30% -$13.5M 0.06% 370
2015
Q3
$38.3M Buy
368,036
+115,529
+46% +$14.8M 0.07% 305
2015
Q2
$31.2M Buy
252,507
+211,260
+512% +$26.6M 0.05% 429
2015
Q1
$4.87M Buy
41,247
+2,822
+7% +$338K 0.01% 1276
2014
Q4
$4.58M Buy
38,425
+3,492
+10% +$393K 0.01% 1339
2014
Q3
$3.92M Sell
34,933
-140,175
-80% -$13.3M 0.01% 1433
2014
Q2
$16.6M Sell
175,108
-150,957
-46% -$10.6M 0.03% 652
2014
Q1
$21.5M Buy
326,065
+73,035
+29% +$5.78M 0.04% 521
2013
Q4
$20M Sell
253,030
-62,186
-20% -$4.33M 0.04% 540
2013
Q3
$23.9M Sell
315,216
-39,623
-11% -$3.15M 0.04% 483
2013
Q2
$28.3M Buy
+354,839
New +$26.1M 0.05% 415

Other funds holding VRTX